Elranatamab monotherapy in the real-word setting in relapsed-refractory multiple myeloma: results of the French compassionate use program on behalf of the IFM.

ABSTRACT:

SUBMITTER: Malard F 

PROVIDER: S-EPMC11655550 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature